Reviewed against publicly available manufacturer product information and peer-reviewed anatomy sources. Last source review: July 23, 2026.
Layer 1: Clinical Concern Routes
| What the client says | What to assess first | What it means for the clinic |
|---|---|---|
| “The line is visible even when my face is relaxed.” | Fold depth, tissue deflation, and whether the crease is truly a melomental fold | This can enter the direct fold-softening menu, with the SKU selected by the desired transition, brand preference, and pack. |
| “My mouth corners pull down when I speak or rest.” | Movement pattern, oral-commissure position, and whether a static groove is also present | Route the movement component separately, then use the fold menu when a coexisting static groove also needs softening. |
| “There is a hollow beside my chin and the jawline looks broken.” | Pre-jowl hollowing, chin proportion, mandibular contour, and the local fold | This may be a lower-face support and contour pathway rather than direct line filling alone. |
| “The lower face looks heavy or loose.” | Skin laxity, jowl descent, tissue weight, and whether volume loss is actually dominant | Adding volume may not answer the main complaint. Keep tightening, resurfacing, or surgical assessment as separate categories. |
| “The line runs from my nose toward my mouth.” | Whether the client is describing a nasolabial fold rather than a marionette line | Route to the nasolabial-fold pathway; the location changes the consultation and product evidence. |
| “I want the whole lower face to look less tired.” | Which visible features create that impression: fold, mouth-corner position, chin, jawline, skin, or several factors | Create a combination assessment and assign each concern to its own role before building the inventory plan. |
The useful first decision is not “Which marionette lines filler wins?” It is “Which concern pathway is this patient actually in?” The SKU comparison begins only after the direct static-fold or deep lower-face filler pathway has been confirmed.

Marionette lines are the creases that travel from the corners of the mouth toward the chin. They are different from nasolabial folds, which run from the sides of the nose toward the mouth. That location check sounds basic, but it prevents a clinic from using the same explanation, photograph standard, and stock decision for two different lower-face concerns.
The line itself can also be only one visible part of the problem. Peer-reviewed anatomical discussion describes several possible contributors, including changes in bone and deep fat, tissue descent, ligament effects, muscle compression, and jowl formation. That is why a marionette lines filler may be helpful in one consultation and incomplete in another.
Five Clinical Assessment Paths Before Product Selection
Table of Contents
TogglePath 1: A true static fold needs softening
If the crease is visible at rest and the principal goal is to soften the shadow between the oral commissure and chin, a direct fold-correction pathway is reasonable to assess. The visual target should be described as softening, not erasing every line. A completely flat lower face can look inconsistent during expression and may not be achievable or desirable.
For this pathway, the marionette lines filler discussion should focus on how the named SKU is positioned for deeper folds, the kind of visual transition it supports in a mobile lower-face area, and how its pack fits the clinic’s service menu. This is where BELOTERO Intense, Restylane Defyne, and other deep-fold roles can be compared without pretending that they are interchangeable.
Path 2: Mouth-corner movement is part of the concern
A client may call the downward appearance a “line” even when the strongest change happens during speech, frowning, or resting muscle pull. The clinic should record the appearance at rest and during movement. If the main issue is movement-led, the neuromodulator category can be assessed as a separate service. A filler can address a coexisting static groove, while the movement component keeps its own consultation pathway.
This distinction is commercially useful. It stops the clinic from ordering a deeper gel for a service that has not been correctly defined, and it creates a clearer consultation menu: static fold, movement-led mouth corner, or a combination assessment.
Path 3: The pre-jowl or chin changes the lower-face line
Some patients point to the marionette area when the stronger visual break sits beside the chin or along the jawline. If a pre-jowl hollow, limited chin projection, or discontinuous mandibular contour contributes to the shadow, the clinic may need a support-and-contour pathway rather than direct line correction alone.
This does not mean every marionette line requires chin or jawline filler. It means the clinic should name the contributing region before it assigns a product role. The Chin Filler Guide can be used when the assessment shows that chin proportion is a separate part of the request.
Path 4: Skin laxity or surface texture is dominant
When loose skin, heavier jowling, or etched surface creasing is the main concern, added volume may not deliver the requested visual direction. A patient who wants tighter skin is not necessarily asking for a deeper fold filler, even if the line and the laxity occupy the same photograph.
The clinic should keep skin-quality, resurfacing, tightening, and surgical pathways distinct from a marionette lines filler menu. A combination plan may ultimately be appropriate, but each category should have its own expected result and evidence.
Path 5: The concern is actually adjacent
A fold above the mouth belongs to the nasolabial pathway. A hollow lateral to the mouth may involve the cheek or midface. A central lower-face concern may be more strongly related to the chin. Routing the client to the correct region creates a more useful product and service-menu discussion.
For an upper fold, continue to the Nasolabial Fold Filler Guide. If age-related midface volume is part of the assessment, the Cheek Filler Guide explains five distinct cheek-product roles.
Layer 2: Product and Inventory Routes Within the Direct-Fold Pathway
The comparison below is not a second list of five clinical causes. All five products sit inside the direct-fold or deep lower-face filler pathway. Manufacturer information is used to define the documented area or product-family role, while FillersFairy listings show the current sales pack. The clinic can then separate the products by intended visual direction, brand system, portfolio crossover, packaging, and service-menu fit.
| Exact SKU | Best-fit direct-fold or inventory demand | Expected visual direction | Clinic inventory role | Pack format | Manufacturer evidence used for this route | Ordering and stock-planning note | What makes it different from the other four |
|---|---|---|---|---|---|---|---|
| BELOTERO Intense with Lidocaine | A deeper static fold where the patient still wants a soft transition during normal lower-face movement | Direct smoothing of a pronounced line without making “rigid correction” the consultation goal | Deep-fold softening and BELOTERO family consultations | Current FillersFairy selector: confirm the selected Intense presentation; current page lists a 1 × 1 mL syringe format | Official BELOTERO material positions Intense for deeper lines and folds, includes marionette lines within the around-the-mouth pathway, and emphasizes natural integration in a mobile area. | Use the exact Intense with Lidocaine selection and current 1 × 1 mL format as the dedicated soft-transition fold SKU. | It gives the menu a direct deep-fold role centered on tissue integration and natural movement rather than adjacent structural contouring. |
| Restylane Defyne with Lidocaine | A confirmed deep static fold where the patient prefers a Restylane option designed around expression-conscious support | Softer deep laugh lines with dynamic-looking support rather than a frozen lower-face appearance | Expressive lower-face fold menu and Restylane portfolio pathway | Current FillersFairy listing: 1 × 1 mL | Official Restylane material positions Defyne for deeper facial wrinkles and folds, reports a study pathway that included marionette lines, and emphasizes dynamic support. | Use the exact 1 × 1 mL presentation as the expression-conscious Restylane option after a direct-fold route has been confirmed. | It brings dynamic-support language into a deep-fold Restylane service; it is not presented as the answer to a movement-only mouth-corner concern. |
| JUVÉDERM VOLIFT with Lidocaine | A confirmed deeper lower-face line plus named JUVÉDERM demand or a clinic building a connected JUVÉDERM lip and deep-line menu | Deep-line correction that can sit inside a coordinated lower-face and lip service menu | JUVÉDERM deep-line, lower-face, and lip-shaping menu | Current FillersFairy listing: 2 × 1 mL | Official JUVÉDERM information positions VOLIFT with Lidocaine for deeper wrinkles and lines as well as lip shaping, giving it a useful lower-face service crossover. | The 2 × 1 mL pack supports a coordinated deep-line and lip-shaping menu within the JUVÉDERM family. | It connects a deep-line consultation with a named JUVÉDERM lip and lower-face pathway, making the two-syringe pack commercially useful for a defined multi-service menu. |
| Neuramis Deep Lidocaine | A confirmed direct-fold or deep-wrinkle service plus Neuramis preference and a Korean 1 mL inventory route | Fold softening planned alongside a separately classified nasolabial or lower-face concern | Neuramis-brand deep-wrinkle and nasolabial-fold crossover menu | Current FillersFairy listing: 1 × 1 mL | Official Medytox material positions the Neuramis series for deeper facial wrinkles and gives Neuramis Deep Lidocaine a lower-face and nasolabial-fold role. | Use the 1 × 1 mL presentation for Neuramis brand requests and a Korean lower-face wrinkle menu. | It gives Neuramis-preferring clinics a 1 mL Korean lower-face wrinkle route with documented nasolabial adjacency, rather than duplicating a JUVÉDERM or Restylane brand request. |
| REVOLAX Deep with Lidocaine | A confirmed deep-wrinkle service plus REVOLAX preference and a Korean 1.1 mL single-syringe inventory route | A defined deep-fold direction that remains separate from lip enhancement, chin support, and skin-tightening claims | Korean 1.1 mL single-syringe deep-wrinkle inventory | Current FillersFairy listing: 1 × 1.1 mL | Official Across information positions REVOLAX Deep within the brand’s deeper facial-wrinkle and tissue-restoration range. | Use the 1 × 1.1 mL presentation as the REVOLAX portfolio route and a distinct single-syringe stock format. | It adds a REVOLAX-brand route and a 1.1 mL single-syringe stock format, giving the Korean menu a different portfolio and pack choice from Neuramis Deep. |
These five product routes are complementary, not a ranking and not a one-to-one match with the five clinical assessment paths. Inside a confirmed direct-fold pathway, a clinic can separate soft-transition demand, expression-conscious Restylane demand, the JUVÉDERM family crossover, Neuramis preference, and the REVOLAX 1.1 mL portfolio route.
Official manufacturer references used for this comparison: BELOTERO around-the-mouth and deeper-fold information, Restylane Defyne and studied marionette-line information, JUVÉDERM VOLIFT deep-line information, Medytox Neuramis product information, and Across REVOLAX range information. These are manufacturer pages, not competing supplier pages.
How Long Does Marionette Lines Filler Last?
A practical planning range for many HA marionette lines filler and lower-face-fold treatments is around 6 to 12 months. This range helps a clinic discuss maintenance and stock cycles, but it is not a fixed outcome for every product, patient, or site.
- Restylane Defyne: official manufacturer information gives a result reference of up to 1 year for facial wrinkles and folds and discusses marionette lines within the studied lower-face pathway.
- BELOTERO Intense: official Asia-Pacific product information states that enhancements usually last 12 months or longer, depending on the area and individual factors.
- JUVÉDERM products: official family information gives a broader 9-to-24-month range across products and facial areas; that family range should not be presented as a 24-month VOLIFT result for marionette lines.
For Neuramis Deep Lidocaine and REVOLAX Deep with Lidocaine, record each SKU’s own published repeat window and re-order cycle in the clinic stock sheet. Results can vary with the product, treated area, tissue, movement, metabolism, treatment plan, and follow-up timing.
How Should Clinics Set Marionette-Line Expectations?
The clinic can describe an intended visual direction—such as softening a static groove or reducing the dominance of a shadow—but should not guarantee complete removal or a fixed degree of correction. If chin, jawline, lip, skin quality, or movement also contributes to the appearance, those concerns should remain separately documented rather than being folded into one marionette-line result claim.
Before-and-after photography should show the lower face at rest and during a consistent expression, with the same camera distance, head position, lighting, and follow-up interval. The record should identify the exact product and state whether the lips, chin, jawline, cheek, nasolabial fold, or a movement-related category was also treated. Otherwise, the photograph cannot show which part of the change came from the marionette lines filler.
Marionette-Line Filler Safety
A marionette lines filler treatment should be administered only by a qualified professional who understands lower-face anatomy and is prepared to recognise and manage complications. The fact that an HA filler has product-specific management options does not make treatment risk-free. Unexpected or escalating pain, skin that becomes pale, grey, blue, or unusually mottled, visual changes, or neurological symptoms require immediate assessment rather than routine follow-up. A clinic should also pause before adding more product when the patient has an unknown previous filler, active infection, persistent nodules, unexplained swelling, or suspected migration. Those findings need their own clinical evaluation before a new stock item or additional syringe is assigned to the case. This guide intentionally does not provide injection points, dose, or tissue-plane instructions; product handling and use should follow the exact supplied documentation and the judgement of an appropriately trained practitioner. For the broader on-site safety route, see Dermal Filler Safety Information.
Build the Purchasing Mix Around the Service Menu
| Service menu | Useful SKU combination | Why the combination has a purpose |
|---|---|---|
| Direct Fold-Softening Menu | BELOTERO Intense + Restylane Defyne | Separates a direct deeper-fold/tissue-integration brief from an expression-conscious dynamic-support brief. |
| Lower-Face and Lip Menu | JUVÉDERM VOLIFT | Creates one JUVÉDERM route for deep lines, lower-face contour discussion, and lip shaping, with each service documented separately. |
| Korean Lower-Face Menu | Neuramis Deep + REVOLAX Deep | Offers two positive Korean-brand routes: a 1 mL Neuramis lower-face pathway and a 1.1 mL REVOLAX portfolio pathway with a different brand request and stock format. |
| Expanded Five-SKU Menu | All five exact SKUs, when demand supports each role | Adds all five only when consultation demand and turnover justify each direct-fold, brand-family, portfolio, or pack role. |
Price can still be part of marionette lines filler purchasing, but the comparison should begin with the clinic’s menu role, expected visual direction, preferred brand family, and pack format. Korean origin is a brand and inventory preference, and each product’s own strengths should remain the basis of its menu position. A smaller clinic may begin with one direct-fold product and one clearly different brand or pack route, then add the other SKUs as consultation demand and stock turnover justify expansion.
Before Ordering: Match the SKU to the Defined Role
A marionette lines filler order should follow a completed concern route. If the patient is routed to movement assessment, chin or pre-jowl support, laxity or skin quality, or another facial area, the clinic should not force that concern into the five-SKU table. After a direct static-fold pathway is confirmed, the clinic can compare soft-transition demand, expression-conscious Restylane demand, the JUVÉDERM family crossover, Neuramis preference, and the REVOLAX single-syringe route against the exact product name, current pack, appointment menu, and expected re-order cycle.
FillersFairy is a distributor and sourcing channel. Its product pages can confirm the current sales presentation and pack. Before ordering, request the current product document, exact batch, expiry, packaging, traceability files, and manufacturer instructions for the SKU being added to the lower-face menu.
Frequently Asked Questions
What are marionette lines?
Marionette lines, also called melomental folds, run from the corners of the mouth toward the chin. They are not the same as nasolabial folds, which run from the sides of the nose toward the mouth.
Is filler always the best treatment for marionette lines?
No. A static fold or local volume deficit may fit a filler pathway, while movement-led mouth corners, skin laxity, heavier jowls, or an adjacent chin and jawline concern may need a different or combined assessment.
How long does marionette lines filler last?
A useful planning range for many HA lower-face fold treatments is around 6 to 12 months. Product-specific references can be longer, but the exact result depends on the SKU, area, individual tissue, movement, metabolism, and treatment plan.
Which filler is best for marionette lines?
First confirm that the concern belongs to the direct static-fold or deep lower-face filler pathway. Within that pathway, there is no universal winner: compare the documented product role, intended visual direction, brand system, exact pack, and clinic menu before choosing among BELOTERO Intense, Restylane Defyne, JUVÉDERM VOLIFT, Neuramis Deep, and REVOLAX Deep.
Can a clinic stock both international and Korean HA fillers for this area?
Yes. A mixed inventory is useful when each SKU has a named service-menu role, its own pack logic, and a distinct brand or portfolio purpose. Korean products should be described by their own strengths and brand preferences rather than as substitutes for international brands.
Choose the Next Route
| Assessment result | Next FillersFairy route |
|---|---|
| The line is actually a nasolabial fold | Continue to the Nasolabial Fold Filler Guide. |
| Chin or pre-jowl support is a separate part of the concern | Use the Chin Filler Guide before assigning a structural product. |
| The concern is primarily lip contour or volume | Continue to the Lip Filler Guide and keep the lip and lower-face-fold roles separate. |
| The clinic has defined a marionette lines filler role | Review the five product pages above or browse the Dermal Filler Collection, then request current pack, batch, and traceability documents for the exact SKU. |
Final purchasing conclusion: all five products can have a positive place in a lower-face inventory when the clinic has demand for each documented role. A smaller clinic may begin with one direct-fold product and one clearly different brand or pack route, then add the other SKUs as consultation demand and stock turnover justify expansion. The objective is not to rank the brands from high to low, but to prevent five products from being presented as interchangeable marionette-line fillers or as automatic answers to five different clinical causes.





